Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMID 14671246)

Published in Stroke on December 11, 2003

Authors

T Neumann-Haefelin1, R du Mesnil de Rochemont, J B Fiebach, A Gass, C Nolte, T Kucinski, J Rother, M Siebler, O C Singer, K Szabo, A Villringer, P D Schellinger, Kompetenznetz Schlaganfall Study Group

Author Affiliations

1: Department of Neurology, University Hospitals, Frankfurt, Germany. tnh@rz.uni-frankfurt.de

Articles citing this

Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One (2008) 1.25

Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry (2005) 1.02

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol (2014) 1.02

Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence. J Cereb Blood Flow Metab (2010) 1.01

Dynamics of regional distribution of ischemic lesions in middle cerebral artery trunk occlusion relates to collateral circulation. J Cereb Blood Flow Metab (2010) 0.98

The protective effects of T cell deficiency against brain injury are ischemic model-dependent in rats. Neurochem Int (2012) 0.94

Tissue at risk in the deep middle cerebral artery territory is critical to stroke outcome. Neuroradiology (2011) 0.87

Editorial comment--degree of arterial recanalization: an end point for efficacy in future intravenous thrombolytic trials. Stroke (2003) 0.86

The time of maximum post-ischemic hyperperfusion indicates infarct growth following transient experimental ischemia. PLoS One (2013) 0.82

Simultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery m1 occlusion. Interv Neuroradiol (2011) 0.81

A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS). BMC Neurol (2015) 0.81

Outcome of MRI-based intravenous thrombolysis in carotid-T occlusion. J Neurol (2012) 0.79

Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol (2016) 0.79

Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep (2004) 0.78

Fibrinolytic therapy in acute stroke. Curr Cardiol Rev (2010) 0.78

Incomplete mechanical recanalization of middle cerebral artery occlusions facilitates endogenous recanalization within 5 h. J Neurointerv Surg (2012) 0.78

Hyperglycaemia, insulin therapy and critical penumbral regions for prognosis in acute stroke: further insights from the INSULINFARCT trial. PLoS One (2015) 0.76

The hemodynamic status within 24 h after intravenous thrombolysis predicts infarct growth in acute ischemic stroke. J Neurol (2011) 0.76

Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis (2012) 0.76

Impact of reperfusion after 3 hours of symptom onset on tissue fate in acute cerebral ischemia. J Neuroimaging (2008) 0.75

Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice. Neurobiol Dis (2016) 0.75

Articles by these authors

Heparin treatment in sinus venous thrombosis. Lancet (1991) 5.02

Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71

Spontaneous low frequency oscillations of cerebral hemodynamics and metabolism in human adults. Neuroimage (2000) 4.07

CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke (2002) 3.74

Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke (2001) 2.26

Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke (1999) 2.25

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet (2001) 2.13

A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke (1999) 2.10

A diffusion-weighted MRI study of acute ischemic distal arm paresis. Neurology (2001) 2.09

No evidence for early decrease in blood oxygenation in rat whisker cortex in response to functional activation. Neuroimage (2001) 2.07

Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke (2004) 2.06

Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males. J Clin Microbiol (1992) 2.05

Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology (2004) 2.04

Anticoagulation monitoring and cerebral microemboli detection. Lancet (1994) 2.03

Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol (2000) 1.94

Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke (1998) 1.87

Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil (1999) 1.78

Characterization of CBF response to somatosensory stimulation: model and influence of anesthetics. Am J Physiol (1993) 1.77

A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging (1999) 1.76

Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J Biol Chem (1992) 1.76

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63

Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke (2002) 1.62

The level of C/EBP protein is critical for cell migration during Drosophila oogenesis and is tightly controlled by regulated degradation. Mol Cell (2000) 1.62

Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62

Clinicotopographical correlation of corticospinal tract stroke: a color-coded diffusion tensor imaging study. Stroke (2003) 1.61

Simultaneous recording of cerebral blood oxygenation changes during human brain activation by magnetic resonance imaging and near-infrared spectroscopy. J Cereb Blood Flow Metab (1996) 1.57

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation (2001) 1.56

Neural correlates of the volitional regulation of the desire for food. Int J Obes (Lond) (2011) 1.55

Intracranial tuberculomas mimicking a malignant disease in an immunocompetent patient. Acta Neurochir (Wien) (2003) 1.52

Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: assessment with MR and transcranial Doppler sonography. AJNR Am J Neuroradiol (1998) 1.50

Prevalence of stroke and stroke symptoms: a population-based survey of 28,090 participants. Neuroepidemiology (2008) 1.50

Diffusion MRI in multiple sclerosis. Neurology (2005) 1.49

Failure to demonstrate peri-infarct depolarizations by repetitive MR diffusion imaging in acute human stroke. Stroke (2000) 1.47

How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke (1996) 1.47

Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem (1992) 1.46

Cerebral microemboli in patients with antiphospholipid syndrome. Lupus (1997) 1.45

Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol (2008) 1.45

Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab (1998) 1.44

Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells. Biochem J (1991) 1.44

[FEES in the stroke unit: recommendations for implementation in the clinical routine]. Nervenarzt (2013) 1.42

Noninvasive functional imaging of human brain using light. J Cereb Blood Flow Metab (2000) 1.41

The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia (2006) 1.41

Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci U S A (1992) 1.40

[Indication for emergent revascularisation of acute carotid occlusion]. Chirurg (2007) 1.39

Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements. Brain Res (1997) 1.38

Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem (1997) 1.37

Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke (2002) 1.37

Determining changes in NIR absorption using a layered model of the human head. Phys Med Biol (2001) 1.36

Bilateral internal carotid artery dissection mimicking inflammatory demyelinating disease. J Neuroimaging (2003) 1.36

Diffusion-weighted imaging for the differential diagnosis of disorders affecting the hippocampus. Cerebrovasc Dis (2011) 1.34

High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood (2001) 1.33

Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors. FASEB J (2001) 1.33

In-vivo confocal scanning laser microscopy of the cerebral microcirculation. J Microsc (1992) 1.32

Physical model for the spectroscopic analysis of cortical intrinsic optical signals. Phys Med Biol (2000) 1.30

Effect of aging on stimulus-reward association learning. Neuropsychologia (2004) 1.30

Reward-based decision-making and aging. Brain Res Bull (2005) 1.29

Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol (2001) 1.29

Somatotopic organization of human secondary somatosensory cortex. Cereb Cortex (2001) 1.28

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27

Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis (2008) 1.23

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke (2000) 1.23

Dural sinus thrombosis: value of venous MR angiography for diagnosis and follow-up. AJR Am J Roentgenol (1994) 1.22

Influence of different ionic and pH environments on structural alterations of poliovirus and their possible relation to virus uncoating. J Gen Virol (1991) 1.22

Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J Biol Chem (1997) 1.20

fMRI shows multiple somatotopic digit representations in human primary somatosensory cortex. Neuroreport (2000) 1.19

MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem (2000) 1.19

Serial analysis of the apparent diffusion coefficient time course in human stroke. Neuroradiology (2002) 1.18

Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke (1995) 1.18

Consequences of mutations within the C terminus of the FHL1 gene. Neurology (2009) 1.18

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17

Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol (1992) 1.17

Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry (1998) 1.15

Cross talk in the Lambert-Beer calculation for near-infrared wavelengths estimated by Monte Carlo simulations. J Biomed Opt (2002) 1.15

Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. J Neurochem (2000) 1.14

Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) (2005) 1.11

Magnetic labeling of activated microglia in experimental gliomas. Neoplasia (2002) 1.11

An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging (1996) 1.11

Near-infrared spectroscopy: does it function in functional activation studies of the adult brain? Int J Psychophysiol (2000) 1.11

How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol (2012) 1.10

Acute stroke patterns in patients with internal carotid artery disease: a diffusion-weighted magnetic resonance imaging study. Stroke (2001) 1.10

Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol (2000) 1.10

Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res (1995) 1.10

Bed-side assessment of cerebral perfusion in stroke patients based on optical monitoring of a dye bolus by time-resolved diffuse reflectance. Neuroimage (2004) 1.09

Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry (2006) 1.09

Noninvasive assessment of changes in cytochrome-c oxidase oxidation in human subjects during visual stimulation. J Cereb Blood Flow Metab (1999) 1.09

Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am J Physiol (1994) 1.08

Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke (1998) 1.07

Human infectious corneal ulcer caused by Pythium insidiosum. Cornea (1993) 1.07

Cerebral oxygenation changes in response to motor stimulation. J Appl Physiol (1985) (1996) 1.06

A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05